Synergism of heat shock protein 90 and histone deacetylase inhibitors in synovial sarcoma. - Wikidata - wikimedia - TriplyDB

Synergism of heat shock protein 90 and histone deacetylase inhibitors in synovial sarcoma.

Synergism of heat shock protein 90 and histone deacetylase inhibitors in synovial sarcoma.

http://www.wikidata.org/entity/Q37138320

about

Targeted therapies in sarcomas: challenging the challenge Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomas Clinical efficacy of vorinostat in a patient with leiomyosarcoma.Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs Of mice and men: opportunities to use genetically engineered mouse models of synovial sarcoma for preclinical cancer therapeutic evaluation Alternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.Evaluating the Effect of HDAC8 Inhibition in Malignant Peripheral Nerve Sheath Tumors.

P2860

Q21285014-FE5BFAAC-6D5A-4A18-8B84-F46DAB3457C8 Q33742171-4F6FC136-5196-42B2-AF61-054823022B53 Q35789686-65E7D2DE-3E8C-4292-BACA-5997F8897FA5 Q35823157-7AF42CF6-61A1-4761-9A88-B294DF7043A1 Q37222595-9B5EC9D1-C2CA-4F22-97E8-6A106875825B Q37622446-42C87E59-EAFB-41E6-A0F9-02DC80A8C324 Q39069350-BB894C98-35FF-445D-B243-23E8C0E85D57 Q51373889-D2B63B8A-CA05-407B-A90B-15F542BFA9B9

P2860

Synergism of heat shock protein 90 and histone deacetylase inhibitors in synovial sarcoma.

http://www.wikidata.org/entity/Q37138320

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Synergism of heat shock protei ...... nhibitors in synovial sarcoma.

@en

Synergism of heat shock protei ...... nhibitors in synovial sarcoma.

@nl

type

label

Synergism of heat shock protei ...... nhibitors in synovial sarcoma.

@en

Synergism of heat shock protei ...... nhibitors in synovial sarcoma.

@nl

prefLabel

Synergism of heat shock protei ...... nhibitors in synovial sarcoma.

@en

Synergism of heat shock protei ...... nhibitors in synovial sarcoma.

@nl

P1433

Q37138320-F13EBD5D-1C23-46D7-82C7-B8B5C6518D58

P1476

Q37138320-D965E2E2-53F2-403D-A948-D63023C51443

P2093

Q37138320-1D3134BB-9995-40DA-B482-17988AD85BC4

Q37138320-268E5BF8-53A6-41EA-8B99-FC9BD6B8BA56

Q37138320-52D729D1-6121-4785-A83F-48747B376440

Q37138320-67970767-9721-4139-A032-4EE04AAB466B

Q37138320-D545306E-C121-4FA7-85BA-7B482351F297

P2860

Q37138320-042CC1F0-DD9C-4CED-A5B5-EED79DFB099D

Q37138320-0C926016-C581-44C7-A0D0-9BCC2591A686

Q37138320-0D7BBF54-BA2B-45DA-9A58-FE04409BD660

Q37138320-1D283218-0FB3-4638-871F-A26465BD6BEB

Q37138320-20E6C2B2-2B01-44D1-B807-CED2324CDF36

Q37138320-27A0AEFA-D993-4C34-9C47-3C4BA88292E6

Q37138320-2F7A9F24-C2D7-4FD6-BC78-A8324F8086B5

Q37138320-31C06823-7CD5-46AF-B961-0A59CBC796F9

Q37138320-3960E7A1-7920-4D02-B024-408D6F8350AC

Q37138320-3C4A0C60-A80E-4270-9A01-EBA14A406805

P304

Q37138320-4B5C17D0-FBDC-49F7-AF5F-8066374E271A

P31

Q37138320-EE084BEB-E00A-4BE1-B6D8-A63991266C32

P356

Q37138320-AACB4FA5-EB89-4985-8F53-6BF8019F2E2A

P478

Q37138320-479A224F-5EC7-4265-9A6B-C9C91DA66696

P577

Q37138320-E36803FA-4EE4-4F5D-A8DA-CF2DE5A2D1BF

P5875

Q37138320-91F9A0CE-77DF-4D83-9C9A-E7AD3DDB6E9F

P698

Q37138320-C44EB601-FF59-4831-8866-362FCB63FDEA

P932

Q37138320-813288F9-9BDB-42E5-8B1C-7ED024895F05

P356

P1433

P1476

Synergism of heat shock protei ...... nhibitors in synovial sarcoma.

@en

P2093

Anne Nguyen

http://www.w3.org/2001/XMLSchema#string

Belinda Campbell

http://www.w3.org/2001/XMLSchema#string

Le Su

http://www.w3.org/2001/XMLSchema#string

Neal M Poulin

http://www.w3.org/2001/XMLSchema#string

Torsten O Nielsen

http://www.w3.org/2001/XMLSchema#string

P2860

Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor kappaB-mediated transcription

Fusions of the SYT and SSX genes in synovial sarcoma.

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

Chromatin modifications and their function

Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation

Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90

Protein kinase C-associated kinase can activate NFkappaB in both a kinase-dependent and a kinase-independent manner

Duration of nuclear NF-kappaB action regulated by reversible acetylation

Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis

Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway

P304

794901

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2009/794901

http://www.w3.org/2001/XMLSchema#string

P478

2009

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24238517

http://www.w3.org/2001/XMLSchema#string

P698

19325926

http://www.w3.org/2001/XMLSchema#string

P932

2659882

http://www.w3.org/2001/XMLSchema#string